Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/bgs/2023/06/23/biotech-stocks-ripe-for-a-short-squeeze

6/23/2023 8:49 AM

Subscribers to Chart of the Week received this commentary on Sunday, June 18. The biotech sector comes with a large ‘buyer beware’ sticker. Most stocks in the sector are prone to volatile moves depen...

$26.4 Billion Amgen Buyout Sends Horizon Stock Soaring

https://www.schaeffersresearch.com/content/news/2022/12/12/264-billion-amgen-buyout-sends-horizon-stock-soaring

12/12/2022 9:36 AM

The shares of Horizon Therapeutics PLC (NASDAQ:HZNP) are up 14.9% at $111.75 this morning, following reports that Amgen (AMGN) will buy the biopharmaceutical company in a deal worth roughly $26.4 bi...

Horizon Therapeutics Reconsiders Several Big Buyout Bids

https://www.schaeffersresearch.com/content/news/2022/11/30/horizon-therapeutics-reconsiders-several-big-buyout-bids

11/30/2022 10:10 AM

Horizon Therapeutics PLC (NASDAQ:HZNP) is surging this morning, last seen up 29.6% at $102.10, following news that the company is reconsidering possible bids from Amgen (AMGN), Sanofi (SASY), and John...

First Week of August Brings Manufacturing, Services Data

https://www.schaeffersresearch.com/content/news/2022/07/28/first-week-of-august-brings-manufacturing-services-data

7/28/2022 12:00 PM

August will kick off next week at the height of the earnings season, but besides a slew of quarterly earnings reports, traders will be sifting through multiple economic indicators as well. Specificall...

Blue-Chip Stock Could Soon Cool from Recent Rally

https://www.schaeffersresearch.com/content/analysis/2022/05/31/blue-chip-stock-could-soon-cool-from-recent-rally

5/31/2022 3:07 PM

Blue-chip name Amgen, Inc. (NASDAQ:AMGN) earlier reported its olpasiran therapy helped reduce cholesterol levels in patients with atherosclerotic cardiovascular disease (ASCVD), according to topline ...

PEOPLE ALSO SEARCH FOR